JAK抑制剂与斑秃 - Suppr

Suppr

超能文献

JAK inhibitors and alopecia areata.

作者信息

Gilhar Amos, Keren Aviad, Paus Ralf

机构信息

Skin Research Laboratory, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

出版信息

Lancet. 2019 Jan 26;393(10169):318-319. doi: 10.1016/S0140-6736(18)32987-8.

DOI:10.1016/S0140-6736(18)32987-8

PMID:30696569

Abstract

摘要

相似文献

JAK inhibitors and alopecia areata.

Lancet. 2019 Jan 26;393(10169):318-319. doi: 10.1016/S0140-6736(18)32987-8.

JAK Inhibitors for Treatment of Alopecia Areata.

J Invest Dermatol. 2018 Sep;138(9):1911-1916. doi: 10.1016/j.jid.2018.05.027. Epub 2018 Jul 26.

Janus Kinase Inhibitors in the Treatment of Alopecia Areata.

Prague Med Rep. 2023;124(1):5-15. doi: 10.14712/23362936.2023.1.

Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology: A Review of Their Utilization, Safety Profile and Future Applications.

Skin Therapy Lett. 2022 Jan;27(1):4-9.

[JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].

Harefuah. 2020 Jan;159(1):38-42.

Emerging drugs for alopecia areata: JAK inhibitors.

Expert Opin Emerg Drugs. 2018 Mar;23(1):77-81. doi: 10.1080/14728214.2018.1444750. Epub 2018 Feb 26.

Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?

Int J Dermatol. 2022 Nov;61(11):e457-e458. doi: 10.1111/ijd.15946. Epub 2021 Oct 29.

Role of janus kinase inhibitors in the treatment of alopecia areata.

Drug Des Devel Ther. 2018 Jul 27;12:2323-2335. doi: 10.2147/DDDT.S172638. eCollection 2018.

The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature.

J Cutan Med Surg. 2019 May/Jun;23(3):289-297. doi: 10.1177/1203475418824079. Epub 2019 Jan 28.

JAK Inhibitors for the Treatment of Pediatric Alopecia Areata.

J Investig Dermatol Symp Proc. 2020 Nov;20(1):S31-S36. doi: 10.1016/j.jisp.2020.04.005.

引用本文的文献

Janus kinase inhibitors for alopecia areata: a review of clinical data.

Front Immunol. 2025 May 13;16:1577115. doi: 10.3389/fimmu.2025.1577115. eCollection 2025.

Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment.

J Dermatol. 2025 Mar;52(3):510-514. doi: 10.1111/1346-8138.17628. Epub 2025 Jan 15.

A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database.

J Dermatol. 2024 Sep;51(9):1157-1171. doi: 10.1111/1346-8138.17381. Epub 2024 Jul 25.

Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study.

Arch Dermatol Res. 2024 Jul 23;316(7):487. doi: 10.1007/s00403-024-03225-4.

Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology.

Int J Mol Sci. 2024 Jun 28;25(13):7100. doi: 10.3390/ijms25137100.

Recent advances in the genetics of alopecia areata.

Med Genet. 2023 Apr 5;35(1):15-22. doi: 10.1515/medgen-2023-2004. eCollection 2023 Apr.

Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date.

Drugs Context. 2023 Sep 25;12. doi: 10.7573/dic.2023-6-2. eCollection 2023.

Alopecia Areata: Current Treatments and New Directions.

Am J Clin Dermatol. 2023 Nov;24(6):895-912. doi: 10.1007/s40257-023-00808-1. Epub 2023 Aug 22.

Prescription Pattern of Tofacitinib for Alopecia Areata Among the Dermatologists in Saudi Arabia: A Cross-Sectional Study.

Cureus. 2023 Jun 15;15(6):e40445. doi: 10.7759/cureus.40445. eCollection 2023 Jun.

The potential of regulatory T cell-based therapies for alopecia areata.

Front Immunol. 2023 May 2;14:1111547. doi: 10.3389/fimmu.2023.1111547. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

JAK inhibitors and alopecia areata.

Lancet. 2019 Jan 26;393(10169):318-319. doi: 10.1016/S0140-6736(18)32987-8.

JAK Inhibitors for Treatment of Alopecia Areata.

J Invest Dermatol. 2018 Sep;138(9):1911-1916. doi: 10.1016/j.jid.2018.05.027. Epub 2018 Jul 26.

Janus Kinase Inhibitors in the Treatment of Alopecia Areata.

Prague Med Rep. 2023;124(1):5-15. doi: 10.14712/23362936.2023.1.

Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology: A Review of Their Utilization, Safety Profile and Future Applications.

Skin Therapy Lett. 2022 Jan;27(1):4-9.

[JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].

Harefuah. 2020 Jan;159(1):38-42.

Emerging drugs for alopecia areata: JAK inhibitors.

Expert Opin Emerg Drugs. 2018 Mar;23(1):77-81. doi: 10.1080/14728214.2018.1444750. Epub 2018 Feb 26.

Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?

Int J Dermatol. 2022 Nov;61(11):e457-e458. doi: 10.1111/ijd.15946. Epub 2021 Oct 29.

Role of janus kinase inhibitors in the treatment of alopecia areata.

Drug Des Devel Ther. 2018 Jul 27;12:2323-2335. doi: 10.2147/DDDT.S172638. eCollection 2018.

The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature.

J Cutan Med Surg. 2019 May/Jun;23(3):289-297. doi: 10.1177/1203475418824079. Epub 2019 Jan 28.

JAK Inhibitors for the Treatment of Pediatric Alopecia Areata.

J Investig Dermatol Symp Proc. 2020 Nov;20(1):S31-S36. doi: 10.1016/j.jisp.2020.04.005.

引用本文的文献

Janus kinase inhibitors for alopecia areata: a review of clinical data.

Front Immunol. 2025 May 13;16:1577115. doi: 10.3389/fimmu.2025.1577115. eCollection 2025.

Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment.

J Dermatol. 2025 Mar;52(3):510-514. doi: 10.1111/1346-8138.17628. Epub 2025 Jan 15.

A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database.

J Dermatol. 2024 Sep;51(9):1157-1171. doi: 10.1111/1346-8138.17381. Epub 2024 Jul 25.

Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study.

Arch Dermatol Res. 2024 Jul 23;316(7):487. doi: 10.1007/s00403-024-03225-4.

Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology.

Int J Mol Sci. 2024 Jun 28;25(13):7100. doi: 10.3390/ijms25137100.

Recent advances in the genetics of alopecia areata.

Med Genet. 2023 Apr 5;35(1):15-22. doi: 10.1515/medgen-2023-2004. eCollection 2023 Apr.

Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date.

Drugs Context. 2023 Sep 25;12. doi: 10.7573/dic.2023-6-2. eCollection 2023.

Alopecia Areata: Current Treatments and New Directions.

Am J Clin Dermatol. 2023 Nov;24(6):895-912. doi: 10.1007/s40257-023-00808-1. Epub 2023 Aug 22.

Prescription Pattern of Tofacitinib for Alopecia Areata Among the Dermatologists in Saudi Arabia: A Cross-Sectional Study.

Cureus. 2023 Jun 15;15(6):e40445. doi: 10.7759/cureus.40445. eCollection 2023 Jun.

The potential of regulatory T cell-based therapies for alopecia areata.

Front Immunol. 2023 May 2;14:1111547. doi: 10.3389/fimmu.2023.1111547. eCollection 2023.